Literature DB >> 26189181

Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.

Zdena Kristofikova1, Jan Ricny, Jana Sirova, Daniela Ripova, Irit Lubitz, Michal Schnaider-Beeri.   

Abstract

It has been suggested that advanced glycation end (AGE) products, via cognate receptor activation, are implicated in several diseases, including Alzheimer's disease. The NMDA receptor-nitric oxide pathway appears to be influenced by AGE products and involved in the pathogenesis of this type of dementia. In this study, C57BL/6J (WT) and transgenic (Tg2576) mice expressing human mutant amyloid precursor protein were kept on prolonged (8 months) diets containing regular or high amounts of AGE products. After the decapitation of 11-months old mice, brain tissue analyses were performed [expressions of the NR1, NR2A and NR2B subunits of NMDA receptors, activities of neuronal, endothelial and inducible nitric oxide synthase (nNOS, eNOS and iNOS)]. Moreover, levels of malondialdehyde and of human amyloid β 1-42 were estimated. We found increased activity of nNOS in WT mice maintained on a high compared to regular AGE diet; however, no similar differences were found in Tg2576 mice. In addition, we observed an increase in NR1 expression in Tg2576 compared to WT mice, both kept on a diet high in AGE products. Correlation analyses performed on mice kept on the regular AGE diet supported close links between particular subunits (NR2A-NR2B, in WT as well as in Tg2576 mice), between subunits and synthase (NR2A/NR2B-nNOS, only in WT mice) or between particular synthases (nNOS-iNOS, only in WT). Correlation analysis also revealed differences between WT mice kept on both diets (changed correlations between NR2A/NR2B-nNOS, between nNOS-eNOS and between eNOS-iNOS). Malondialdehyde levels were increased in both Tg2576 groups when compared to the corresponding WT mice, but no effects of the diets were observed. Analogously, no significant effects of diets were found in the levels of soluble or insoluble amyloid β 1-42 in Tg2576 mice. Our results demonstrate that prolonged ingestion of AGE products can influence the NMDA receptor-nitric oxide pathway in the brain and that only WT mice, not Tg2576 mice, are able to maintain homeostasis among subunits and synthases or among particular synthases. The prolonged application of AGE products enhanced differences between 11-months old Tg2576 and WT mice regarding this pathway. Observed differences in the pathway between WT mice kept on regular or high AGE diets suggest that the prolonged application of a diet low in AGE products could have beneficial effects in older or diabetic people and perhaps also in people with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26189181     DOI: 10.1007/s11064-015-1654-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

Authors:  V V Shuvaev; I Laffont; J M Serot; J Fujii; N Taniguchi; G Siest
Journal:  Neurobiol Aging       Date:  2001 May-Jun       Impact factor: 4.673

2.  Ultrastructural evidence that insoluble microtubules are components of the neurofibrillary tangle.

Authors:  M A Pappolla; J Alzofon; J McMahon; T J Theodoropoulos
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1990

3.  DHA inhibited AGEs-induced retinal microglia activation via suppression of the PPARγ/NFκB pathway and reduction of signal transducers in the AGEs/RAGE axis recruitment into lipid rafts.

Authors:  Li Wang; Ka Chen; Kai Liu; Yong Zhou; Ting Zhang; Bin Wang; Mantian Mi
Journal:  Neurochem Res       Date:  2015-01-18       Impact factor: 3.996

4.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

5.  Inhibition of L-arginine metabolizing enzymes by L-arginine-derived advanced glycation end products.

Authors:  Ying-Ling Lai; Sae Aoyama; Ryoji Nagai; Noriyuki Miyoshi; Hiroshi Ohshima
Journal:  J Clin Biochem Nutr       Date:  2010-02-27       Impact factor: 3.114

6.  Dietary advanced glycation end products are associated with decline in memory in young elderly.

Authors:  Rebecca K West; Erin Moshier; Irit Lubitz; James Schmeidler; James Godbold; Weijing Cai; Jaime Uribarri; Helen Vlassara; Jeremy M Silverman; Michal Schnaider Beeri
Journal:  Mech Ageing Dev       Date:  2014-07-15       Impact factor: 5.432

Review 7.  Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

Authors:  Velandai Srikanth; Annette Maczurek; Thanh Phan; Megan Steele; Bernadette Westcott; Damian Juskiw; Gerald Münch
Journal:  Neurobiol Aging       Date:  2009-05-22       Impact factor: 4.673

8.  Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein.

Authors:  Kiyoshi Niwa; Ken Kazama; Linda Younkin; Steven G Younkin; George A Carlson; Costantino Iadecola
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

Review 9.  RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

Authors:  Louis J Sparvero; Denise Asafu-Adjei; Rui Kang; Daolin Tang; Neilay Amin; Jaehyun Im; Ronnye Rutledge; Brenda Lin; Andrew A Amoscato; Herbert J Zeh; Michael T Lotze
Journal:  J Transl Med       Date:  2009-03-17       Impact factor: 5.531

10.  High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.

Authors:  Irit Lubitz; Jan Ricny; Dana Atrakchi-Baranes; Chen Shemesh; Efrat Kravitz; Sigal Liraz-Zaltsman; Anna Maksin-Matveev; Itzik Cooper; Avshalom Leibowitz; Jaime Uribarri; James Schmeidler; Weijing Cai; Zdena Kristofikova; Daniela Ripova; Derek LeRoith; Michal Schnaider-Beeri
Journal:  Aging Cell       Date:  2016-01-19       Impact factor: 9.304

View more
  1 in total

1.  Scattering Angle Resolved Optical Coherence Tomography Detects Early Changes in 3xTg Alzheimer's Disease Mouse Model.

Authors:  Michael R Gardner; Vikram Baruah; Gracie Vargas; Massoud Motamedi; Thomas E Milner; Henry G Rylander
Journal:  Transl Vis Sci Technol       Date:  2020-04-24       Impact factor: 3.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.